Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 42 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
TERMOFARMA from Waasmunster, company number BE0822076681, closed financial year 2025 with a result of € 131,866 after tax. For that financial year TERMOFARMA recorded a gross margin of € 234,469 and equity of € 2.2 million. Compared with financial year 2024, the result moved from € 142,301 to € 131,866. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.
€ 2.2 million
▼ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 131,866
▼ 7% vs 2024
Profit after tax over the fiscal year.
€ 236,361
▲ 1% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 205,263 paid out
More than the year’s profit went to the shareholders; reserves fell.
Debts at end 2025
€ 739,759
▼ 16% vs 2024
€ 146,275 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 5,587
Supplier invoices still open on the last day of the fiscal year.
€ 65,352
▲ 20% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 331,502 | € 257,280 | € 255,420 | € 234,469 | ▼ 8% |
| Profit after taxes | € 220,851 | € 145,377 | € 142,301 | € 131,866 | ▼ 7% |
| Equity | € 1,973,203 | € 2,118,580 | € 2,260,881 | € 2,187,484 | ▼ 3% |
| Total debts | € 1,607,561 | € 1,480,438 | € 1,426,253 | € 1,539,710 | ▲ 8% |
| Cash | € 133,278 | € 193,838 | € 234,147 | € 236,361 | ▲ 1% |
| Retained profit | € 1,967,003 | € 2,112,380 | € 2,254,681 | € 2,181,284 | ▼ 3% |
| Dividend | € 0 | € 0 | € 0 | € 205,263 | |
| Bank debt | € 1,218,568 | € 1,048,892 | € 877,044 | € 739,759 | ▼ 16% |
| Balance sheet total | € 3,580,764 | € 3,599,019 | € 3,687,135 | € 3,727,194 | ▲ 1% |
Key figures of TERMOFARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to TERMOFARMA?
What happened at TERMOFARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 131,866 (▼ 7% vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Waasmunster. KBO
In short
From € 220,851 profit in 2022 to € 131,866 profit in 2025.
Paid € 275,011 in corporate taxes since 2022.
Best year ever: 2022, with € 220,851 profit.
Paid out € 205,263 in dividends to the owners in total.
Management
Behind TERMOFARMA is Geraldine Termote. Geraldine Termote is also behind APOTEEK TERMOTE.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Hoogstraat 148
9250 Waasmunster
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0822.076.681
- VAT number
- BE 0822.076.681
- Registered office
- Hoogstraat 148, 9250 Waasmunster
- Names & denominations
- TERMOFARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 8 January 2010
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering